Utama › Sindrom Kesukaran Pernafasan › Texas
Kajian klinikal Sindrom Kesukaran Pernafasan di Texas
14 kajian untuk Sindrom Kesukaran Pernafasan sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Amarillo
- Research Site, Dallas
- Research Site, El Paso
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450Comparing Surfactant Administration Through Supraglottic Airway and Thin Catheter for Preterm Infants
- Parkland Health and Hospital Systems, Dallas
Mengambil peserta
0 Hours – 72 Hours · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07030270Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
- McGovern Medical School - UT Physicians Pulmonary Medicine - Texas Medical Center, Houston
- Baylor Scott & White Health, Temple
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT05947955Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
- Christus Children's Hospital, San Antonio
Mengambil pesertaFasa 3
1 Hour – 24 Hours · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06776783JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
- Baylor All Saints Medical Center, Fort Worth
- Baylor St Luke's Medical Center, Houston
- Houston Methodist Hospital, Houston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06703073JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
- Baylor All Saints Medical Center, Fort Worth
- Baylor St Luke's Medical Center, Houston
- Houston Methodist Hospital, Houston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06701656JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
- Baylor All Saints Medical Center, Fort Worth
- Baylor St Luke's Medical Center, Houston
- Houston Methodist Hospital, Houston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06701669JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
- Baylor All Saints Medical Center, Fort Worth
- Baylor St Luke's Medical Center, Houston
- Houston Methodist Hospital, Houston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06701682Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
- Baylor College of Medicine / St. Luke's Medical Center, Houston
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT06066502Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
- Direct Biologics Investigational Site, Dallas
- Direct Biologics Investigational Site, Fort Worth
- Direct Biologics Investigational Site, Houston
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 23 Feb 2026 · NCT05354141Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Horizon Clinical Research Group, Houston
- CHRISTUS Trinity Mother Frances Health System, Tyler
Mengambil pesertaKajian pemerhatian
Umur 50 ke atas · Semua jantina · Dikemas kini 5 Ogo 2025 · NCT06122077The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
- Houston Methodist Hospital, Houston
- Houston Methodist Research Institute, Houston
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Apr 2025 · NCT03642002Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome
- Texas Children's Hospital Baylor College of Medicine, Houston
Mengambil pesertaKajian pemerhatian
Umur 0 hingga 21 · Semua jantina · Dikemas kini 15 Nov 2024 · NCT06690801Clazakizumab vs. Placebo - COVID-19 Infection
- Houston Methodist Hospital, Houston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2020 · NCT04494724Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.